Premier Anti-Aging (TSE:4934) 3Q 2024 Results
Key Financial Results
- Sales: 4.79 billion yen (down 25% from the third quarter of 2023).
- Net income: JPY 235 million (up from a JPY 127 million loss in the third quarter of 2023).
- Margins: 4.9% (up from a net loss in Q3’23).
- EPS: ¥26.95 (up from a loss of ¥14.56 in Q3 2023).
All figures shown in the chart above are for the trailing twelve month (TTM) period.
Premier Anti-Aging Revenue Insights
Going forward, Japan’s personal products industry revenue is projected to grow by 4.1%, while remaining flat over the next three years.
Performance Japan’s personal products industry.
The company’s shares are up 9.4% from a week ago.
Risk Analysis
However, it is worth noting that 1 Warning Sign for Premier Anti-Aging It’s something you need to consider.
Valuation is complicated, but we can help make it simple.
investigate Premier Anti-Aging By checking our comprehensive analysis, you can see whether it may be overvalued or undervalued. Fair value estimates, risks and warnings, dividends, insider trading, financial strength.
View your free analysis
Have feedback about this article? Concerns about the content? contact Please contact us directly. Or email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We use only unbiased methodologies to provide commentary based on historical data and analyst forecasts, and our articles are not intended as financial advice. It is not a recommendation to buy or sell stocks, and does not take into account your objectives, or your financial situation. We seek to provide long-term focused analysis driven by fundamental data. Note that our analysis may not take into account the latest price sensitive company announcements or qualitative material. Simply Wall St has no position in any of the stocks mentioned.
Valuation is complicated, but we can help make it simple.
investigate Premier Anti-Aging By checking our comprehensive analysis, you can see whether it may be overvalued or undervalued. Fair value estimates, risks and warnings, dividends, insider trading, financial strength.
View your free analysis
Have feedback about this article? Concerns about the content? Contact us directly. Or email us at editorial-team@simplywallst.com
